Introduction
============

Abdominal adipose tissue, visceral adipose tissue (VAT) in particular, is considered to play a key role in the pathogenesis of insulin resistance and chronic inflammation^[@bib1],\ [@bib2])^, in addition to being an important likely determinant of atherosclerosis^[@bib3],\ [@bib4])^. Although anthropometric obesity indices such as body mass index (BMI) and waist circumference (WC) have been commonly used, these indices do not provide precise information on abdominal adipose tissue. In contrast, computed tomography (CT) can directly assess not only VAT but also subcutaneous adipose tissue (SAT). Several studies have shown that CT-based obesity indices such as area/volume of VAT are associated with clustering of atherosclerosis risk factors^[@bib5]--[@bib7])^, and some studies have reported that CT-based obesity indices are also associated with the measure of atherosclerosis^[@bib8]--[@bib12])^. However, it remains to be determined whether CT-based obesity indices have a stronger relationship with atherosclerosis than anthropometric indices such as BMI. In addition, it is not clear if the association of CT-based obesity indices with atherosclerosis is independent of an index of general obesity such as BMI. These questions are important because a stronger and/or independent association of CT-based index suggests the significant role of abdominal adipose tissue in atherosclerogenesis beyond general obesity.

Carotid intima-media thickness (IMT) assessed using ultrasound is a robust quantitative marker of atherosclerosis^[@bib13],\ [@bib14])^. IMT can be measured non-invasively, and its usefulness as a marker of generalized atherosclerosis has been shown in a Japanese population^[@bib13])^. Furthermore, it has been shown in a Japanese population that the mean carotid IMT was positively associated with the estimated 10-year absolute risk of coronary artery disease death^[@bib15])^. The aim of this study was to examine the associations of carotid IMT with various obesity indices (both CT-based and anthropometric), and to compare strengths of the association for each index among community-dwelling Japanese men.

Methods
=======

Study Design and Participants
-----------------------------

This cross-sectional study used the baseline assessment of the Shiga Epidemiological Study of Subclinical Atherosclerosis (SESSA), which is a prospective population-based cohort study constructed on a random sample from general Japanese residents. Details of the enrollment methods have been reported previously^[@bib16],\ [@bib17])^. In brief, from 2006 to 2008, we randomly selected and invited 2379 Japanese men aged between 40 and 79 years who were residents of Kusatsu City, Shiga, based on the Basic Residents\' Register of the city. A total of 1094 men agreed to participate.

For this study, men who did not undergo carotid artery ultrasound examination (*n* = 33), who did not undergo abdominal CT (*n* = 9), who had missing information for any of body weight, height, WC, or hip circumference (*n* = 46), and who had a history of myocardial infarction or stroke (*n* = 69) were excluded. Therefore, 944 men were included for the final analyses (**[Fig. 1](#F1){ref-type="fig"}**). This study was approved by the institutional review board of Shiga University of Medical Science and written informed consent was obtained from all participants.

![Flow chart of the selection process of participants](jat-26-1102-g001){#F1}

Anthropometric Obesity Indices
------------------------------

Body weight and height were measured while the participant was wearing light clothing without shoes. BMI was calculated as weight (in kilograms) divided by the square of the height (in meters). WC (in centimeters) and hip circumference (in centimeters) were measured twice at the umbilical level and maximal protrusion of the hip in an upright standing position, respectively. All analyses used the mean of two measures. Waist-to-hip ratio (WHR) was calculated as WC divided by hip circumference. Waist-to-height ratio (WHtR) was calculated as WC divided by height (in centimeters)^[@bib17])^.

Abdominal Adipose Tissue
------------------------

A single cross-sectional CT image at the level of the L4-L5 vertebral space was selected to estimate abdominal adipose tissue. We defined adipose tissue within the inside edge of the abdominal wall as VAT, and defined that outside the area of the abdominal wall not including muscular fascia as abdominal SAT. Adipose tissue on CT images was identified tissue showing CT attenuation between −190 and −30 Hounsfield units in the above-defined anatomical cross-sectional area^[@bib17])^. Inner and outer areas of the abdominal wall were manually tracked, and respective cross-sectional areas were calculated using image analysis software (SliceOmatic; Tomovision, Montreal, Canada). Area of abdominal total adipose tissue (TAT) was calculated using the sum of areas of VAT and SAT. All CT images were analyzed at Shiga University Medical Science by a trained physician-researcher who was blinded to the characteristics of participants^[@bib17])^. Two types of CT scanner were used during the examination period: a GE-Imatron C150 Electron Beam Tomography system (GE Medical Systems, South San Francisco, CA; slice thickness, 6 mm) for participants examined between May 2006 and August 2007, and a 16-detector-row CT system (Aquilion-16TM, Toshiba Medical Systems, Tochigi, Japan; slice thickness, 7 mm) for participants examined thereafter. We tested interaction by CT type by inserting a product term (CT type × obesity index) in linear regression models, and found no evidence of the interaction. Therefore, we have presented combined results with adjustment for CT type.

Blood Tests
-----------

Blood specimens were obtained early in the clinic visit after a 12-hour fast. Serum was separated by centrifugation (3000 revolutions/min, for 15 min) at 4 °C within 90 min of blood withdrawal. Glucose concentration was measured using a hexokinase glucose-6-phosphate dehydrogenase enzymatic assay from sodium fluoride-treated plasma, and glycated hemoglobin (HbA1c) was measured using a latex agglutination assay according to the standardized method of the Japanese Diabetes Society (JDS). We then converted JDS values to those of the National Glycohemoglobin Standardization Program (NGSP) using the following formula recommended by the JDS: HbA1c (NGSP) = 1.02 × HbA1c (JDS) + 0.25 (%)^[@bib18])^. Diabetes was defined as fasting plasma glucose ≥ 126 mg/dL, HbA1c (NGSP) ≥ 6.5%, or the use of diabetic medication. Serum triglycerides (TG) and total cholesterol (TC) were measured using enzymatic assays. High-density lipoprotein cholesterol (HDL-C) was measured after heparin-calcium precipitation (Kyowa Medix, Tokyo, Japan)^[@bib19])^. Low-density lipoprotein cholesterol (LDL-C) was calculated using the Friedewald formula^[@bib20])^: LDL-C (mg/dL) = TC (mg/dL) − HDL-C (mg/dL) − TG (mg/dL)/5. This formula is applicable only for participants with TG \< 400 mg/dL^[@bib20])^. Dyslipidemia was defined as LDL-C ≥ 140 mg/dL, HDL-C \< 40 mg/dL, TG ≥ 150 mg/dL or the use of dyslipidemic medication in accordance with the diagnostic criteria for screening by the 2018 Japanese Atherosclerosis Society (JAS) Guidelines^[@bib21])^.

Other Risk Factors
------------------

Blood pressure was measured on the right arm using an automated sphygmomanometer (BP-8800; Omron Health Care, Kyoto, Japan) with an appropriately sized cuff. Participants were asked to empty their bladders for urinalysis and sit quietly for at least 5 min before measuring the blood pressure. The average of two consecutive measures was used for analyses. Hypertension was defined as systolic blood pressure (SBP) ≥ 140 mmHg, diastolic blood pressure (DBP) ≥ 90 mmHg, or use of antihypertensive medication. Alcohol intake was categorized as current drinker, past drinker, or never. Amount of smoking was estimated as pack-years, defined as the product of the number of packs of cigarettes smoked per day with the number of years of smoking (one pack contains 20 cigarettes).

Carotid IMT
-----------

IMT of the common carotid artery, carotid bulb, and internal carotid artery on both right and left sides was measured using an ultrasound device equipped with a 7.5-MHz probe (Xario-660A; Toshiba Medical Systems, Japan), according to the protocol established by the Ultrasound Research Laboratory at the University of Pittsburgh^[@bib15],\ [@bib22])^. For the common carotid artery, both near and far walls were measured 1 cm proximal to the bulb. For the bulb and internal carotid artery segments, only far walls were measured. The IMT was traced using the automatic image reading program of the AMS (Chalmers University of Technology, Gotenburg, Sweden), and the average of the former 8 IMT values measured on both sides were eventually used as carotid IMT in this study. Sonographers received training for carotid scanning provided by the Ultrasound Research Laboratory at the University of Pittsburgh, and were blinded to the characteristics of participants at the time of the scan.

Statistical Analysis
--------------------

Because several continuous variables did not follow a bell-shaped distribution and were strongly skewed, all continuous variables are presented as median and 20^th^ and 80^th^ percentile points. Categorical variables are presented as percentages.

We assessed the following 8 obesity indices: BMI, WC, WHR, WHtR, areas of VAT and SAT, VAT-to-SAT ratio (VSR), and VAT-to-TAT ratio (VTR). In single-index analyses, we inserted only one obesity index in a model and estimated crude and adjusted slopes of carotid IMT per 20th to 80th percentile of the index by using linear regression. In BMI-adjustment analyses, we simultaneously inserted BMI and other one obesity index in one model to test if the association of one of the other 7 indices was independent of BMI. Interpretation of a beta coefficient (i.e., a slope of "delta") of carotid IMT as per 20--80th percentile is that carotid IMT at the 80 percentile of an obesity index is thicker by "delta" than carotid IMT at the 20 percentile of the index. We chose such standardization because of strongly skewed distributions in some obesity indices. Similar approach to our method in standardization has been adopted in previous studies^[@bib23]--[@bib26])^. In addition, T-values by Student\'s *t* test for all slopes of carotid IMT in the regression models were shown (the null hypothesis: slope of delta = zero). BMI-adjustment analyses were conducted because BMI is the most frequently used obesity index for its simplicity and good precision^[@bib27])^. Because some obesity indices were highly correlated with BMI, we computed variance inflation factor to consider potential problems from multicollinearity in the analyses. For the analysis of single adjustment and of BMI-adjustment, we constructed the following 4 models: unadjusted model; Model 1, adjusted for age and CT type; Model 2, Model 1 with further adjustments for lifestyle risk factors of alcohol intake (current vs. non-current) and smoking (pack-years); and Model 3, Model 2 with further adjustments for metabolic risk factors of hypertension (yes vs. no), diabetes (yes vs. no), and dyslipidemia (yes vs. no).

Japanese men tend to start losing weight, as reflected by a decline in BMI, at around 60--69 years old^[@bib28])^. We therefore repeated the same analyses after age-stratification into 2 subgroups (\< 65 vs. ≥ 65 years) to assess any differences in slope between the two age-groups. The interaction by age group was tested by adding a product term (age group × obesity index) in a model. All statistical analyses were conducted using SAS version 9.4 software (SAS Institute, Cary, NC). A *P*-value of \< 0.05 was considered statistically significant.

Results
=======

Characteristics of the 944 male participants are presented in **[Table 1](#T1){ref-type="table"}**. Medians of age, BMI, WC, WHR, and WHtR were 64.4 years, 23.3 kg/m^2^, 85.0 cm, 0.92, and 0.51, respectively. Medians of VAT area, SAT area, VSR, and VTR were 114 cm^2^, 115 cm^2^, 0.95, and 0.49, respectively. Prevalence of hypertension, diabetes, and dyslipidemia was 54.0%, 18.1%, and 55.5%, respectively. Median carotid IMT was 816 µm. All obesity indices except VSR and VTR correlated well with each other after adjusting for age (**[Supplemental Table 1](#T6){ref-type="table"}**).

###### Characteristics of participants (944 men, aged 40 to 79 years old, free of stroke and myocardial infarction in 2006--2008, Shiga, Japan)

  ------------------------------ -------------------
  Age (years)                    64.4 (55.7, 73.4)
  Weight (kg)                    64.2 (57.1, 72.7)
  Height (cm)                    166 (161, 171)
  BMI (kg/m^2^)                  23.3 (21.0, 25.9)
  WC (cm)                        85.0 (78.5, 91.6)
  Hip circumference (cm)         92.0 (87.9, 96.7)
  WHR                            0.92 (0.88, 0.96)
  WHtR                           0.51 (0.47, 0.55)
  VAT area (cm^2^)               114 (71, 159)
  SAT area (cm^2^)               115 (80, 157)
  TAT area (cm^2^)               229 (151, 316)
  VSR                            0.95 (0.71, 1.30)
  VTR                            0.49 (0.42, 0.57)
  Smoking (pack-years)           24.2 (1.0, 47.0)
  Alcohol Intake (%)             
      Current                    77.1
      Past                       5.3
      Never                      17.6
  SBP (mmHg)                     135 (121, 152)
  DBP (mmHg)                     80 (71, 89)
  Fasting glucose (mg/dL)        97 (89, 110)
  HbA1c (NGSP) (%)               5.8 (5.5, 6.4)
  TC (mg/dL)                     207 (181, 235)
  HDL-C (mg/dL)                  57 (45, 71)
  LDL-C (mg/dL)                  122 (100, 150)
  TG (mg/dL)                     104 (72, 162)
  Hypertension (%)               54.0
  Diabetes (%)                   18.1
  Dyslipidemia (%)               55.5
  CT type (%)                    
      Electron beam tomography   67.3
        Multi-detector-row       32.7
  Carotid IMT (µm)               816 (692, 985)
  ------------------------------ -------------------

Values are presented as median (20th percentile, 80th percentile), or %. Abbreviations: BMI: body mass index; WC: waist circumference; WHR: waist-to-hip ratio; WHtR: waist-to-height ratio; VAT: visceral adipose tissue; SAT: abdominal subcutaneous adipose tissue; TAT: abdominal total adipose tissue, defined as (VAT area + SAT area); VSR: VAT-to-SAT ratio; VTR: VAT-to-TAT ratio; IMT: intimamedia thickness; SBP: systolic blood pressure; DBP: diastolic blood pressure; TC: total cholesterol; HDL-C: high density lipid cholesterol; LDL-C: low density lipid cholesterol; TG: triglycerides.

###### Age-adjusted Spearman\'s Correlation Coefficients Among Obesity Indices (944 men, aged 40 to 79 years old, examined in 2006--2008, Shiga, Japan)

             BMI                                     WC                                     WHR     WHtR                                   VAT area   SAT area   VSR
  ---------- --------------------------------------- -------------------------------------- ------- -------------------------------------- ---------- ---------- --------
  WC         0.867                                   \-                                     \-      \-                                     \-         \-         \-
  WHR        0.645                                   0.825                                  \-      \-                                     \-         \-         \-
  WHtR       0.882                                   0.930                                  0.844   \-                                     \-         \-         \-
  VAT area   0.710                                   0.794                                  0.700   0.766                                  \-         \-         \-
  SAT area   0.799                                   0.833                                  0.658   0.811                                  0.683      \-         \-
  VSR        −0.049[\*](#tf5){ref-type="table-fn"}   0.017[\*](#tf5){ref-type="table-fn"}   0.104   0.010[\*](#tf5){ref-type="table-fn"}   0.427      −0.291     \-
  VTR        −0.049[\*](#tf5){ref-type="table-fn"}   0.017[\*](#tf5){ref-type="table-fn"}   0.104   0.010[\*](#tf5){ref-type="table-fn"}   0.427      −0.291     −1.000

*p*-value \> 0.05, otherwise all *P*-values for coefficient were ≤ 0.001.

Abbreviations: BMI: body mass index; WC: waist circumference; WHR: waist-to-hip ratio; WHtR: waist-to-height ratio; VAT: visceral adipose tissue; SAT: abdominal subcutaneous adipose tissue; VSR: VAT-to-SAT ratio; VTR: VAT-to-TAT ratio; TAT: abdominal total adipose tissue, defined as (VAT area + SAT area).

In the single-index analyses (**[Table 2](#T2){ref-type="table"}**), obesity indices other than VSR and VTR showed significant positive associations with carotid IMT after adjusting for age, CT type, alcohol intake, and smoking (Models 1, 2). Further adjustment for hypertension, diabetes, and dyslipidemia (Model 3) attenuated the associations, but the slopes remained significant for all indices except VSR and VTR. Throughout the multivariable- adjusted models, associations of CT-based obesity indices were no stronger than those of anthropometric indices, and BMI showed the strongest association with carotid IMT. For example, adjusted slopes (in µm) per 20^th^--80^th^ percentiles of BMI, WC, WHR, WHtR, VAT area, and SAT area were 38.3, 33.6, 29.7, 35.5, 29.0, and 22.8, respectively, in Model 3. In BMI-adjustment analyses (**[Table 3](#T3){ref-type="table"}**), none of the other 7 indices remained statistically significant in Models 2 and 3. In contrast, the association of BMI remained statistically significant even with simultaneous adjustment for any CT-based index in Models 2 and 3. All variance inflation factors for BMI and other indices were \< 5.2, less than a concerning level of 10^[@bib29])^, and none of the corresponding standard errors took extremely large values relative to the ones in single adjustment models, all of which suggest that multicollinearity is unlikely to be a concern in obtaining our estimates^[@bib30])^.

###### Crude and adjusted slope of carotid IMT per 20^th^ to 80^th^ percentile of a single obesity index (944 men, aged 40 to 79 years old, in 2006--2008, Shiga, Japan)

             Unadjusted   Model1       Model2   Model3                                                                                                           
  ---------- ------------ ------------ -------- ---------- ------ ------------ ----- ---------- ------ ------------- ----- ---------- ------ ------------- ----- ----------
  BMI        31.2         11.5, 50.8   3.1      0.002      49.8   32.7, 66.9   5.7   \< 0.001   49.9   33.0, 66.8    5.8   \< 0.001   38.3   20.5, 56.2    4.2   \< 0.001
  WC         39.2         19.5, 59.0   3.9      \< 0.001   46.7   29.5, 63.8   5.3   \< 0.001   46.2   29.1, 63.3    5.3   \< 0.001   33.6   15.6, 51.7    3.7   \< 0.001
  WHR        66.3         47.8, 84.8   7.0      \< 0.001   45.0   28.4, 61.5   5.3   \< 0.001   42.5   25.9, 59.1    5.0   \< 0.001   29.7   12.1, 47.3    3.3   0.001
  WHtR       70.8         51.0, 90.7   7.0      \< 0.001   49.1   31.3, 66.8   5.4   \< 0.001   48.6   31.0, 66.3    5.4   \< 0.001   35.5   16.7, 54.2    3.7   \< 0.001
  VAT area   41.7         21.8, 61.7   4.1      \< 0.001   44.8   27.4, 62.2   5.0   \< 0.001   43.4   26.0, 60.8    4.9   \< 0.001   29.0   11.0, 48.1    3.1   0.002
  SAT area   15.7         −2.0, 33.4   1.7      0.082      32.5   16.8, 48.1   4.1   \< 0.001   33.7   18.2, 49.2    4.3   \< 0.001   22.8   6.7, 38.9     2.8   0.006
  VSR        26.7         7.2, 46.2    2.7      0.007      11.6   −5.5, 28.8   1.3   0.183      8.6    −8.5, 25.7    1.0   0.326      2.7    −14.3, 19.7   0.3   0.756
  VTR        27.7         6.7, 48.9    2.6      0.010      11.9   −6.6, 30.4   1.3   0.208      8.3    −10.2, 26.9   0.9   0.377      2.3    −16.1, 20.7   0.3   0.804

Model1: adjusted for age and CT types (electron beam tomography vs multi-detector-row); Model2: further adjusted for alcohol intake, smoking; Model3: further adjusted for hypertension, diabetes, and dyslipidemia. T-value was the value by Student\'s *t* test for each slope of carotid IMT per 20th to 80th percentiles of obesity indices. Abbreviations: IMT: intima-media thickness; BMI: body mass index; WC: waist circumference; WHR: waist-to-hip ratio; WHtR: waist-to-height ratio; VAT: visceral adipose tissue; SAT: abdominal subcutaneous adipose tissue; VSR: VAT-to-SAT ratio; VTR: VAT-to-TAT ratio; TAT: abdominal total adipose tissue, defined as (VAT area + SAT area).

###### Adjusted slope of carotid IMT per 20^th^ to 80^th^ percentiles of BMI and another obesity index in one model (944 men, 40--79 years old, examined in 2006--2008, Shiga, Japan)

             Unadjusted   Model1 ± BMI    Model2 ± BMI   Model3 ± BMI                                                                                                                
  ---------- ------------ --------------- -------------- -------------- ------- ------------- ------ ---------- ------- ------------- ------ ---------- ------- ------------- ------ ----------
  WC         50.8         9.7, 91.9       2.4            0.016          12.8    −22.9, 48.5   0.7    0.483      8.7     −27.2, 44.7   0.5    0.633      0.6     −35.3, 36.6   0.0    0.973
  BMI        −13.1        −53.9, 27.8     −0.6           0.53           38.6    2.9, 74.3     2.1    0.034      42.2    6.6, 77.9     2.3    0.020      37.8    2.23, 73.4    2.1    0.037
                                                                                                                                                                                     
  WHR        76.2         52.9, 99.4      6.4            \< 0.001       24.2    2.9, 45.5     2.2    0.026      19.2    −2.2, 40.6    1.8    0.079      11.5    −10.3, 33.2   1.0    0.301
  BMI        −16.9        −41.2, 7.3      −1.4           0.170          33.9    11.9, 56.0    3.0    0.003      37.4    15.4, 59.3    3.3    \< 0.001   31.5    9.4, 53.6     2.8    0.005
                                                                                                                                                                                     
  WHtR       164.2        126.1, 202.4    8.5            \< 0.001       15.2    −23.8, 54.1   0.8    0.445      11.5    −27.4, 50.4   0.6    0.562      0.8     −38.3, 39.9   0.0    0.968
  BMI        −105.6       −142.6, −68.6   −5.6           \< 0.001       36.8    −0.8, 74.3    1.9    0.055      40.0    2.6, 77.4     2.1    0.036      37.7    0.4, 74.9     2.0    0.047
                                                                                                                                                                                     
  VAT area   39.0         10.5, 67.6      2.7            0.007          17.6    −7.3, 42.5    1.4    0.166      13.6    −11.4, 38.6   1.1    0.287      4.5     −20.8, 29.8   0.4    0.727
  BMI        3.7          −24.3, 31.8     0.3            0.795          37.4    12.9, 61.9    3.0    0.003      40.3    15.9, 64.7    3.2    0.001      35.4    10.9, 59.8    2.8    0.005
                                                                                                                                                                                     
  SAT area   −22.3        −53.1, 8.6      −1.4           0.157          −14.0   −41.0, 13.1   −1.0   0.312      −10.9   −37.9, 16.0   −0.8   0.426      −13.5   −40.3, 13.4   −1.0   0.325
  BMI        51.6         17.1, 86.0      2.9            0.003          62.4    32.5, 92.3    4.1    \< 0.001   59.8    30.1, 89.4    4.0    \< 0.001   50.4    20.5, 80.2    3.3    0.001
                                                                                                                                                                                     
  VSR        29.5         10.0, 48.9      3.0            0.003          15.1    −1.8, 32.0    1.8    0.080      12.1    −4.8, 29.0    1.4    0.159      7.0     −9.9, 24.0    0.8    0.416
  BMI        33.6         14.0, 53.3      3.4            \< 0.001       50.8    33.7, 67.9    5.8    \< 0.001   50.7    33.8, 67.7    5.9    \< 0.001   39.2    21.2, 57.2    4.3    \< 0.001
                                                                                                                                                                                     
  VTR        30.1         9.1, 51.2       2.8            0.005          14.8    −3.5, 33.0    1.6    0.113      12.1    −4.8, 29.0    1.4    0.159      7.0     −9.9, 24.0    0.8    0.416
  BMI        33.0         13.4, 52.7      3.3            0.001          50.5    33.4, 67.6    5.8    \< 0.001   50.7    33.8, 67.7    5.9    \< 0.001   39.2    21.2, 57.2    4.3    \< 0.001

Model1: adjusted for age and CT types (electron beam tomography vs multi-detector-row); Model2: further adjusted for alcohol intake, smoking; Model3: further adjusted for hypertension, diabetes, and dyslipidemia. T-value was the value by Student\'s *t* test for each slope of carotid IMT per 20th to 80th percentiles of obesity indices. Abbreviations: IMT: intima-media thickness; BMI: body mass index; WC: waist circumference; WHR: waist-to-hip ratio; WHtR: waist-to-height ratio; VAT: visceral adipose tissue; SAT: abdominal subcutaneous adipose tissue; VSR: VAT-to-SAT ratio; VTR: VAT-to-TAT ratio; TAT: abdominal total adipose tissue, defined as (VAT area + SAT area).

Age-stratified analyses showed that obesity indices in the \< 65-year-old subgroup were overall stronger in point estimates than those in the ≥ 65-year-old subgroup except for VSR and VTR (**[Tables 4](#T4){ref-type="table"}** and **[5](#T5){ref-type="table"}**). However, no statistical evidence of interaction by age group was observed in all the models for the association between carotid IMT and obesity indices.

###### Crude and Adjusted Slope of Carotid IMT per 20th to 80th Percentile of Obesity Indices (485 men, \< 65 years old, examined in 2006--2008, Shiga, Japan)

             Unadjusted                              Model 1      Model 2                                 Model 3                                                                                                     
  ---------- --------------------------------------- ------------ --------------------------------------- ------------- --------------------------------------- ------------- --------------------------------------- ------------
  BMI        49.7[\*\*](#tf2){ref-type="table-fn"}   27.7, 71.7   63.6[\*\*](#tf2){ref-type="table-fn"}   43.8, 83.3    63.0[\*\*](#tf2){ref-type="table-fn"}   43.3, 82.8    50.9[\*\*](#tf2){ref-type="table-fn"}   30.1, 71.6
  WC         50.8[\*\*](#tf2){ref-type="table-fn"}   27.6, 73.9   61.0[\*\*](#tf2){ref-type="table-fn"}   40.3, 81.7    60.6[\*\*](#tf2){ref-type="table-fn"}   39.7, 81.4    47.8[\*\*](#tf2){ref-type="table-fn"}   26.0, 69.6
  WHR        56.8[\*\*](#tf2){ref-type="table-fn"}   34.0, 79.9   49.5[\*\*](#tf2){ref-type="table-fn"}   28.8, 70.3    46.8[\*\*](#tf2){ref-type="table-fn"}   25.8, 67.8    31.8[\*](#tf1){ref-type="table-fn"}     9.6, 54.0
  WHtR       73.6[\*\*](#tf2){ref-type="table-fn"}   49.4, 97.9   66.9[\*\*](#tf2){ref-type="table-fn"}   44.9, 88.9    65.7[\*\*](#tf2){ref-type="table-fn"}   43.6, 87.8    51.4[\*\*](#tf2){ref-type="table-fn"}   28.0, 74.7
  VAT area   38.3[\*](#tf1){ref-type="table-fn"}     14.5, 62.1   48.7[\*\*](#tf2){ref-type="table-fn"}   27.3, 70.1    46.8[\*\*](#tf2){ref-type="table-fn"}   25.3, 68.3    30.5[\*](#tf1){ref-type="table-fn"}     7.5, 53.5
  SAT area   18.9                                    −1.2, 39.0   48.2[\*\*](#tf2){ref-type="table-fn"}   29.7, 66.7    48.4[\*\*](#tf2){ref-type="table-fn"}   29.9, 66.9    37.2[\*\*](#tf2){ref-type="table-fn"}   18.2, 56.2
  VSR        19.0                                    −3.2, 41.2   −3.1                                    −23.8, 17.6   −6.5                                    −27.3, 14.4   −14.3                                   −34.9, 6.2
  VTR        20.5                                    −3.7, 44.6   −2.6                                    −25.0, 19.9   −6.2                                    −28.8, 16.3   −14.3                                   −36.5, 8.0

*p*-value \< 0.05;

*P*-value \< 0.001;

Model1: adjusted for age and CT types (electron beam tomography vs multi-detector-row); Model2: further adjusted for alcohol intake, smoking; Model3: further adjusted for hypertension, diabetes, and dyslipidemia. Abbreviations: IMT: intima-media thickness; BMI: body mass index; WC: waist circumference; WHR: waist-to-hip ratio; WHtR: waist-to-height ratio; VAT: visceral adipose tissue; SAT: abdominal subcutaneous adipose tissue; VSR: VAT-to-SAT ratio; VTR: VAT-to-TAT ratio; TAT: abdominal total adipose tissue, defined as (VAT area + SAT area).

###### Crude and Adjusted Slope of Carotid IMT per 20^th^ to 80^th^ Percentile of Obesity Indices (459 men, ≥ 65 years old, examined in 2006--2008, Shiga, Japan)

             Unadjusted                              Model 1      Model 2                               Model 3                                                                                                
  ---------- --------------------------------------- ------------ ------------------------------------- ------------- ------------------------------------- ------------ ------------------------------------- -------------
  BMI        33.6[\*](#tf3){ref-type="table-fn"}     4.2, 63.0    33.9[\*](#tf3){ref-type="table-fn"}   5.4, 62.4     35.6[\*](#tf3){ref-type="table-fn"}   7.5, 63.7    24.6                                  −5.1, 54.3
  WC         35.2[\*](#tf3){ref-type="table-fn"}     7.1, 63.3    32.9[\*](#tf3){ref-type="table-fn"}   5.5, 60.2     32.9[\*](#tf3){ref-type="table-fn"}   5.6, 60.1    20.2                                  −8.8, 49.3
  WHR        48.0[\*\*](#tf4){ref-type="table-fn"}   22.0, 74.1   40.8[\*](#tf3){ref-type="table-fn"}   15.1, 66.4    38.2[\*](#tf3){ref-type="table-fn"}   12.4, 64.1   27.5[\*](#tf3){ref-type="table-fn"}   0.1, 54.9
  WHtR       41.4[\*](#tf3){ref-type="table-fn"}     13.3, 69.5   33.3[\*](#tf3){ref-type="table-fn"}   5.7, 60.9     33.8[\*](#tf3){ref-type="table-fn"}   6.4, 61.3    21.9                                  −7.4, 51.1
  VAT area   43.6[\*](#tf3){ref-type="table-fn"}     15.6, 71.6   42.1[\*](#tf3){ref-type="table-fn"}   14.5, 69.6    40.0[\*](#tf3){ref-type="table-fn"}   13.4, 68.6   30.2[\*](#tf3){ref-type="table-fn"}   0.9, 59.5
  SAT area   20.2                                    −5.8, 46.3   14.5                                  −11.1, 40.0   16.7                                  −8.6, 42.1   4.2                                   −22.5, 30.9
  VSR        28.2                                    −0.7, 57.2   31.4[\*](#tf3){ref-type="table-fn"}   3.3, 59.6     30.0[\*](#tf3){ref-type="table-fn"}   2.1, 57.9    27.0                                  −0.7, 54.7
  VTR        26.7                                    −4.4, 57.9   31.6[\*](#tf3){ref-type="table-fn"}   1.3, 61.9     29.4                                  −0.6, 59.4   26.6                                  −3.2, 56.4

*p*-value \< 0.05;

*p*-value \< 0.001;

Model1: adjusted for age and CT types (electron beam tomography vs multi-detector-row); Model2: further adjusted for alcohol intake, smoking; Model3: further adjusted for hypertension, diabetes, and dyslipidemia. Abbreviations: IMT: intima-media thickness; BMI: body mass index; WC: waist circumference; WHR: waist-to-hip ratio; WHtR: waist-to-height ratio; VAT: visceral adipose tissue; SAT: abdominal subcutaneous adipose tissue; VSR: VAT-to-SAT ratio; VTR: VAT-to-TAT ratio; TAT: abdominal total adipose tissue, defined as (VAT area + SAT area).

Discussion
==========

In this community-based cross-sectional study of Japanese men, areas of VAT and SAT were positively associated with carotid IMT independent of potential confounders, but their strengths of associations tended to be smaller than those of anthropometric indices. Among the obesity indices we studied, BMI was most strongly associated with carotid IMT.

VAT has been considered to play a key role in clustering of cardiovascular risk factors through the mechanisms of inflammation and insulin resistance, and has been proposed as an important determinant of obesity-related metabolic abnormalities^[@bib3],\ [@bib4],\ [@bib31],\ [@bib32])^. Studies have shown strong associations of CT-based obesity indices with insulin resistance and the metabolic syndrome^[@bib5]--[@bib7])^. However, it remained uncertain whether CT-based obesity indices were associated more strongly with atherosclerosis than anthropometric indices. Our results showed that their associations were not stronger, suggesting that CT-based abdominal obesity indices had a more limited role in atherosclerogenesis than previously thought^[@bib10])^, or at least, CT-based indices are not stronger markers of atherosclerosis relative to BMI.

Studies of asymptomatic individuals comparing the strengths of associations of CT-based obesity indices with carotid IMT to anthropometric indices are limited. Among the studies conducted in Japan, Takami and colleagues studied 849 Japanese men (mean age, 50.3 years; mean BMI, 23.5 kg/m^2^) and found that correlation coefficients between CT-based obesity indices and carotid IMT were no larger than those of anthropometric indices including BMI^[@bib10])^. A health check-up-based study of 158 Japanese men showed that the association of carotid IMT was stronger in the highest BMI category (≥ 27.6 kg/m^2^) than the highest category of CT-based indices^[@bib33])^. Those studies conducted in Japan seem consistent with our results. However, considering their use of measure of association being either correlation coefficients^[@bib10])^ or regression coefficients of dichotomized category^[@bib33])^, rather than standardized multivariable-adjusted regression coefficients per continuous exposure variables as in our analyses, comparison of strength of association was difficult to judge from those studies. Some community-based studies outside Japan have compared the strength of association using standardized measures in assessing relationships between atherosclerosis and obesity indices, but the results were inconsistent. For example, in the Rancho Bernardo Study of Caucasian adults aged 55--88 years in the United States, none of the obesity indices (including CT-based indices) were significantly associated with coronary atherosclerosis (as measured by coronary artery calcium) with or without adjustment for risk factors^[@bib34])^. On the contrary, a study of asymptomatic Korean adults who were examined at check-up showed a slightly stronger association in BMI than visceral fat area with coronary atherosclerosis (as measured by coronary artery calcium). However, those results are difficult to interpret because they were presented only as gender-combined estimates with no comments on the absence or presence of interaction by gender^[@bib35])^. Our study was the first community-based study to clearly show a stronger association of BMI with carotid atherosclerosis as compared to CT-based obesity indices, including VAT area. Furthermore, the association between BMI and carotid IMT remained independent of a CT-based obesity index, whereas the opposite was not the case (**[Table 3](#T3){ref-type="table"}**). This finding implies that the association of general obesity with carotid atherosclerosis is strong and adding CT-based obesity measure does not significantly influence the association. We acknowledge that the importance of anthropometric measures of abdominal obesity such as WC independent of BMI should not be ignored, as previously shown in multiple large-scale cohort studies^[@bib36]--[@bib38])^. It is noteworthy, however, that considerably little evidence supports the usefulness of CT-based abdominal obesity indices such as VAT area beyond anthropometric measures in relating to atherosclerosis/cardiovascular disease risk. For example, some Japanese studies showed the association of VAT with (clustering of ) metabolic syndrome^[@bib39],\ [@bib40])^, but those studies did not compare the strength of the association between VAT and anthropometric measures as we did. Furthermore, their outcomes were not a direct measure of atherosclerosis.

In BMI-adjustment analyses (**[Table 3](#T3){ref-type="table"}**), the negative slopes of BMI were observed in the unadjusted model, likely because of the simultaneous adjustment for other obesity index that was well correlated with BMI. However, it is noteworthy that all the negative slopes of BMI were observed only in combination with an anthropometric index, and only in the unadjusted model. The weaker association of BMI (even inverse in some cases) with carotid IMT in unadjusted model was in part because of confounding by age because adjustment for age (and CT type) in Model 1 resulted in a positive and stronger association of BMI in both single-index adjustment analyses (**[Table 2](#T2){ref-type="table"}**) and BMI-adjustment analyses (**[Table 3](#T3){ref-type="table"}**).

Although not significant, slopes of obesity indices tended to be smaller in the older group (≥ 65 years) than in the younger group (**[Tables 4](#T4){ref-type="table"}** and **[5](#T5){ref-type="table"}**). Similar findings have been reported from other populations^[@bib28],\ [@bib41])^. This may be because as men age, the body tends to become leaner, but the risk of atherosclerosis increases. However, additional studies are needed to further explore this possibility.

Our findings should be interpreted with caution. First, as a cross-sectional study, the temporal relationship between obesity indices and carotid IMT cannot be shown. Second, only male residents recruited from a single area of Japan were studied. Our results thus may not be applicable to women or other male populations with characteristics differing from those of our sample. Third, we only assessed one marker of atherosclerosis (carotid IMT) in association with obesity indices. The relationship with other markers may differ from the current study. Fourth, our measure of VAT was area, not volume, based on a single crosssectional CT image. However, the technique for the ascertainment is widely used, and its values were highly correlated with volume^[@bib42],\ [@bib43])^. Therefore, it is less likely that our conclusion is sensitive to difference in the measure of adipose tissue (i.e., area vs. volume). One strength of our study was that we randomly selected a community-based sample with a broad age range, which increases the generalizability of our results to general Japanese men. Use of standardized protocols in assessing exposures (obesity indices) and outcomes (carotid IMT) is another strength of our study.

Conclusions
===========

In community-dwelling Japanese men, anthropometric obesity indices, BMI in particular, were more strongly associated with carotid atherosclerosis than CT-based obesity indices. The association of general obesity with carotid atherosclerosis was strong and adding CT-based obesity measure did not considerably influence the association.
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